Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
August 2012 Volume 6 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August 2012 Volume 6 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
Article

Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells

  • Authors:
    • Xiao-Ying Xu
    • Chun Guo
    • Yu-Xian Yan
    • Yong Guo
    • Rui-Xin Li
    • Mei Song
    • Xi-Zheng Zhang
  • View Affiliations / Copyright

    Affiliations: Institute of Medical Equipment, Academy of Military Medical Sciences, Tianjin 300161, P.R. China, Department of Orthopaedics, First Affiliated Hospital of Henan University, Kaifeng 475000, Henan, P.R. China
  • Pages: 409-415
    |
    Published online on: May 8, 2012
       https://doi.org/10.3892/mmr.2012.908
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Mechanical strain plays a critical role in the formation, proliferation and maturation of bone cells. However, little is known about the direct effects of different magnitudes of mechanical strain on osteoclast differentiation. The aim of the present study was to investigate how the fusion and activation of osteoclasts can be regulated by mechanical strain magnitude using the RAW264.7 mouse monocyte/macrophage cell line as an osteoclast precursor. Mechanical strain (substrate stretching) was applied via a 4-point bending system when RAW cells were treated with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-κB (RANK) ligand (RANKL) for an indicated period of time. The numbers of tartrate-resistant acid phosphatase-positive (TRAP+) and apoptotic cells were counted. The expression of TRAP, matrix metalloproteinase-9 (MMP-9), RANK, cathepsin K and carbonic anhydrase II (CAII) was measured by semi-quantitative RT-PCR, and immunocytochemistry staining for RANK was performed. We found that the number of nuclei per osteoclast derived from RAW cells decreased under low magnitude mechanical strain and increased under high magnitude strain within physiological load with an enhanced fusion of TRAP+ osteoclasts, compared to the control with no mechanical strain. The expression of RANK mRNA was downregulated by low magnitude strain and beyond physiological load, while it was upregulated by high magnitude strain within physiological load, correlating with the increased expression of RANK examined by immunocytochemistry, suggesting the mechanical regulation of RANK expression. There was also an increase in the expression of MMP-9 mRNA in the groups subjected to a mechanical strain of 2,000 and 2,500 µε. No significant differences were detected in the expression of TRAP mRNA, cathepsin K and CAII under mechanical strain compared to the control under no strain (0 µε). These findings indicate that low-magnitude strain suppresses osteoclast fusion and activation, while high-magnitude strain within physiological load promotes osteoclast fusion and activation related to a mechanical magnitude-dependent response of RANK expression. These data, therefore, provide a deeper understanding of how different magnitudes of mechanical strains exert their effects on osteoclastogenesis.

Introduction

Bone is a dynamic tissue that constantly undergoes remodeling in which a coupled process of bone formation and resorption continues throughout life. This remodeling is necessary to maintain the structural integrity of the skeleton under conditions of changing mechanical forces. Over the past few decades, investigators have expounded mechanisms for the adaptive response of bone to mechanical stimuli, including the most well-known theory of mechanostat originally proposed by Frost (1,2). It has been reported that disuse activates remodeling, but inhibits modeling, leading to bone loss, whereas overload inhibits remodeling and activates formation mode modeling, leading to bone gain. Furthermore, strain above 1,500 μɛ evokes bone increase (a positive adaptive response) and a strain below 100 μɛ causes a loss of bone (a negative adaptive response), while a strain ranging from 100 to 1,500 μɛ evokes no response. Bone tissue functionally adjusts its mass and architecture to mechanical stimuli, mainly depending on 2 cell types involved in remodeling, one of which is osteoblasts, engaged in bone formation, and the other is osteoclasts, mainly responsible for bone resorption. Excessive osteoclast bone resorption leads to bone loss resulting in skeletal pathologies, such as rheumatoid arthritis, periodontal disease, postmenopausal osteoporosis, implant osteolysis and tumor-associated bone loss (3). However, the understanding of the cellular mechanisms producing such a mechanically meaningful structure remains poor.

The osteoclast is a macrophage polykaryon developed from the differentiation and fusion of hematopoietic precursors at or near the bone surface in response to the essential tumor necrosis factor (TNF) family-related signal molecule receptor activator of NF-κB (RANK) ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) (4,5). RANKL directly engages a membrane receptor, RANK, on osteoclast precursors and mature osteoclasts to trigger multiple intracellular signaling cascades that stimulate osteoclast gene expression, development, function and survival (6). Mice deficient in RANKL or RANK have severe osteopetrosis due to osteoclastogenesis (7–10).

Bone tissue is sensitive to mechanical strain. In a previous study, in the establishment of a mechanobiology model of bone and functional adaptation, the ulna was subjected to peak strains of 2,000 and 3,000 μɛ, suggesting a dose-dependent adaptation of bone to mechanical stimuli (11). However, to date, little is known about the mechanisms invovled in the dose-response relationship between mechanical stimuli and osteoclasts in vitro. Therefore, in the present study, the cells were stretched with cyclic predominantly uniaxial strain by substrate movement along a given axis in order to mimic the mechanical stimuli within or beyond physiological load. Strain magnitudes ranging from 0 to 5,000 μɛ were applied over a period of 3 days at a constant cycle number and frequency to explore the effect of mechanical strain magnitude on osteoclast fusion and activation.

Materials and methods

Cell culture

The RAW264.7 murine monocyte/macrophage cell line (obtained from the School of Basic Medicine of the Peking Union Medical College, Beijing, China) was used as an osteoclast precursor, that has been shown to differentiate into osteoclast-like cells in the presence of M-CSF and soluble RANKL (PeproTech Inc., Rocky Hill, NJ, USA) over a period of 4–5 days (12–14). The cells were cultured in α-minimal essential medium (α-MEM; Gibco BRL, Rockville, MD, USA) supplemented with 10% (v/v) fetal bovine serum (FBS; Gibco), 1% (v/v) penicillin-streptomycin solution (Gibco), 10 mM HEPES at 37°C in a humidified atmosphere of 95% air and 5% CO2. For treatment with mechanical stretching, the cells were seeded onto 34.8-mm cell culture plates at a density of 5×106 cells/cm2. After overnight incubation, the cells were maintained in α-MEM containing 10% FBS, 1% (v/v) penicillin-streptomycin solution, 10 mM HEPES, M-CSF (40 ng/ml) and RANKL (40 ng/ml) for 7 days. The medium was changed every 3 days.

Application of mechanical strain to cultured cells

A 4-point bending system (invented by the Institute of Medical Equipment, Academy of Military Medical Science, Tianjin, China), composed of a cell culture unit, loading unit and circuit controller, was used to apply uniaxial and homogeneous mechanical strain, as described previously (Fig. 1) (15). Strain magnitudes (substrate stretching) ranged from 1,000 to 5,000 μɛ, with a strain frequency fixed at 0.5 Hz. After treatment with RANKL and M-CSF for 3 days, the cells were divided into 6 groups (0, 1,000, 1,500, 2,000, 2,500 and 5,000 μɛ) at random, and subjected to substrate stretching for 3 days for 1 h per day, keeping the original culture condition unchanged (16). After 3 days of substrate stretching, the cells were harvested for the following experiments. The control culture was grown under the same condition without mechanical strain.

Figure 1

The principle of the mechanical strain (substrate streching) device composed of a cell culture unit, loading unit and circuit controller, supplying uniaxial and homogeneous mechanical strain. (A) Mechanical strain (substrate streching) system. (B) Cell culture unit and loading unit of the mechanical strain (substrate streching) device running in the sterile incubator.

Morphological observation and tartrate-resistant acid phosphatase (TRAP) staining

After substrate stretching, the cells from each group were washed twice with phosphate-buffered saline (PBS) and stained with TRAP, using a leukocyte acid phosphatase kit (Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences, Tianjin, China). The TRAP+ multinucleated cells (≥5 nuclei) in 3 representative fields were manually enumerated as osteoclasts under a microscope.

Immunocytochemistry

The cells were washed 3 times with PBS after substrate stretching and then fixed in 4% (v/v) paraformaldehyde. Permeabilization was performed with 0.2% (v/v) Triton X-100 (Sigma Aldrich Chemical Co., St. Louis, MO, USA), then the cells were incubated in 3% H2O2 to quench the endogenous peroxidase activity. After washing with PBS, the samples were incubated with anti-RANK polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA; working dilution, 1:200) at 4°C overnight using the peroxidase-conjugated mouse IgG SABC kit (Wuhan Boster Biological Technology, Ltd., Wuhan, China). After the peroxidase detection, cells were washed with PBS 4 times using the DAB Chromogenic kit (Wuhan Boster Biological Technology, Ltd.). Seal slide with balsam neutral and average optical density of RANK was calculated. The control samples were incubated in the same way with 0.01 M PBS alone, instead of primary antibody.

Apoptosis of osteoclasts

The cells from each group were washed twice with PBS and then fixed in 4% (v/v) paraformaldehyde. The fixed cells were stained with 1 μg/ml DAPI for 20 min at room temperature. After washing with PBS, the nuclear morphology of the cells was observed by fluorescence microscopy. Triplicate samples were prepared for each group and cells with condensed nuclei were counted in a selected field of each sample.

RT-PCR

The cells from each group were harvested as described above followed by RNA extraction using TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. cDNA was synthesized with 3 μg of total RNA, oligo(dT) primer and the TIANScript RT kit (Tiangen Biotech, Beijing, China). The following primers were used: RANK, TRAP, matrix metalloproteinase-9 (MMP-9), cathepsin K and carbonic anhydrase II (CAII). PCRs were conducted by initial denaturation at 94°C for 3 min 30 sec, with 1 μl of reverse transcriptase product added. The sequences of the used primers are shown in Table I. PCR products were separated by 1.5% agarose gel electrophoresis, stained with ethidium bromide, photographed using Gel-Doc (Bio-Rad) and quantified by density determination using Quantity One image analysis software (Bio-Rad). The results were normalized to β-actin signals determined in parallel for each sample, and the data expressed as a ratio of the target gene to β-actin. All amplicons were of the expected size (Table I), and products were directly sequenced to confirm identities by comparison with sequences published using computation performed at NCBI and the BLAST network service.

Table I

Nucleotide sequences of the used primers.

Table I

Nucleotide sequences of the used primers.

GeneGeneBank™ accession no.Product size (bp)Temperature cycling (cycle no.)Forward (F) and reverse (R) primer sequences (5′-3′)
TRAPNM_00738846594°C, 25 sec; 57°C, 30 sec; 68°C, 35 sec (32) ACACAGTGATGCTGTGTGGCAACTC (F)
CCAGAGGCTTCCACATATATGATGG (R)
MMP-9NM_01359935494°C, 25 sec; 64°C, 30 sec; 68°C, 35 sec (32) CGAGTGGACGCGACCGTAGTTGG (F)
CAGGCTTAGAGCCACGACCATACAG (R)
RANKNM_00939935194°C, 25 sec; 57°C, 30 sec; 68°C, 35 sec (32)ACCTCCAGTCAGCAAGAAGT (F)
TCACAGCCCTCAGAATCCAC (R)
CAIINM_00980140794°C, 25 sec; 54°C, 30 sec; 68°C, 35 sec (32)CTTCAGGACAATGCAGTGC (F)
ATCCAGGTCACACATTCCAGC (R)
Cath KNM_00780236494°C, 25 sec; 56°C, 30 sec; 68°C, 35 sec (32) CTGAAGATGCTTTCCCATATGTGGG (F)
GCAGGCGTTGTTCTTATTCCGAG (R)
β-actinNM_00739330694°C, 25 sec; 55°C, 30 sec; 68°C, 35 sec (32)GAAGAGCTATGAGCTGCCTG (F)
CACAGAGTACTTGCGCTCAG (R)

[i] TRAP, tartrate-resistant acid phosphatase; MMP-9, matrix metalloproteinase-9; RANK, receptor activator of nuclear factor-κB; CAII, carbonic anhydrase II; Cath K, cathepsin K.

Statistical analysis

Data are presented as the means ± SE, typically from 2 to 3 independent trials, each with 3 replicates. Statistical comparisons between the treatment groups were performed using one-way analysis of variance. For simultaneous comparisons between multiple treatments, significant differences were determined using Bonferroni’s post hoc analysis of variance test; p<0.05 denoted a statistically significant difference.

Results

Osteoclasts change morphologically and the number of TRAP-positive multinucleated osteoclasts vary depending on the magnitude of mechanical strain

Osteoclasts in culture with M-CSF and RANKL were observed with representative typical multinuclei. After substrate stretching, the number of TRAP+ multinucleated osteoclasts significantly decreased in the groups subjected to a strain of 1,000 and 1,500 μɛ as compared to the control, whereas there was no significant difference in the groups subjected to a strain of 2,000 and 2,500 μɛ compared to the control (Figs. 2A and B, and 3A).

Figure 2

RAW264.7 cells (5×106/cm2) were cultured in 34.8-mm tissue culture plates with macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor-κB ligand (RANKL). Mechanical strain of different magnitudes was applied for 1 h/day for 3 days and at day 4, but not to the control, keeping the culture condition unchanged. (A) Typical multinucleated cells without substate streching. (B) The number of neclei/cell varied depending on the magnitude of mechanical strain, osteoclasts with ≥5 nuclei were counted at day 7. Results are presented as the means ± SD (n=6). *p<0.05, **p<0.01.

Figure 3

The number of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated osteoclasts and receptor activator of nuclear factor-κB (RANK) expression varied depending on the magnitude of mechanical strain. RAW cells (5×106/cm2) were cultured in 34.8-mm tissue culture plates for 3 days, followed by the cells that were subjected to substrate mechanical stretching at different magnitudes for another 3 days, keeping the culture condition unchanged. After 6 days in culture, immunocytochemistry was performed. (A) TRAP+ multinucleated cells were counted in 3 representative fields. (B) Optical density (mean) of RANK was calculated. Results are presented as the means ± SD (n=6). **p<0.01.

Expression of RANK increases under high mechanical strain within physiological load

RANK is the sole signaling receptor for RANKL in the process of inducing the development and activation of osteoclasts. In immunocytochemistry staining for RANK, the groups subjected to a strain of 2,000 and 2,500 μɛ showed stronger positive staining than the control after substrate stretching (Fig. 3B).

Osteoclast apoptosis is induced by substrate stretching of low magnitude

The number of apoptotic osteoclasts increased with the mechanical strain of 1,000 and 1,500 μɛ compared to the control, whereas no significant stimulation was observed in the groups subjected to a strain of 2,000, 2,500 and 5,000 μɛ (Fig. 4A and B).

Figure 4

The number of apoptotic osteoclasts varied depending on the magnitude of mechanical strain. After 7 days in culture with different magnitudes of mechanical strain, apoptotic cells were counted with DAPI staining in a representative field of each sample. Heatmap shows the relationships between data categories and diverse trends of cell survival between the groups of different mechanical strain magnitudes. Results are presented as the means ± SD (n=6). **p<0.01. CTRL, control.

Expression of RANK and MMP-9 genes differs depending on different magnitudes of mechanical strain

The expression of RANK mRNA increased in the groups subjected to a strain of 2,000 and 2,500 μɛ, while it decreased in the groups subjected to a strain of 1,000, 1,500 and 5,000 μɛ. The expression of MMP9 mRNA increased in the groups subjected to a strain of 2,000 and 2,500 μɛ, while there were no significant differences in the groups subjected to a strain of 1,000, 1,500 and 5,000 μɛ. There were no significant differences in the expression of TRAP, cathepsin K and CAII mRNA under mechanical strain compared to the control (Fig. 5).

Figure 5

Mechanical strain was related to the expression of osteoclast differentiation genes. RAW cells (5×106/cm2) were cultured in 34.8-mm tissue culture plates with receptor activator of nuclear factor-κB ligand (RANKL) and macrophage colony-stimulating factor (M-CSF), and subjected to different magnitudes of mechanical strain (substrate stretching) at day 4. After 3 days of culture with or without mechanical stimulation, total RNA was extracted, and RT-PCR analysis was performed using the primers shown in Table I. The mRNA amount of the target gene/β-actin was calculated. Results represent the means ± SD (n=6). *p<0.05, **p<0.01.

Discussion

Since the pioneering work of Frost, it has become generally accepted that bone tissue maintains its structure throughout life by the coupled activities of bone-forming osteoblasts and bone-resorbing osteoclasts. The skeleton is able to continually adapt to the mechanical environment by adding new bone to withstand increased amounts of loading, and by removing bone in response to unloading or disuse. Furthermore, most adult skeletal diseases are due to excess osteoclastic activity. Studies have shown that mechanical strain inhibits osteoclast differentiation indirectly by osteoblasts and stromal cells (17,18). Other reports have shown that compressive mechanical stress promoted osteoclast formation through RANKL expression in synovial cells (19). Ceratin studies have shown that mechanical strain also directly suppresses osteoclast differentiation (13,20,21); others have proven that mechanical stimuli enhance osteoclast differentiation and activities (22–24). However, little is known about the direct effects of different magnitudes of mechanical strain on osteoclast differentiation.

The amount of nuclei per osteoclast decreased significantly with a mechanical strain of 1,000 and 1,500 μɛ, while the number of osteoclasts with 5 or more nuclei increased when the loading magnitude was tuned to 2,000 and 2,500 μɛ compared to the control with no strain (0 μɛ) (Fig. 2). When TRAP staining was performed, the number of osteoclasts was found to be downregulated by low mechanical strain (Fig. 3A). It is well known that RANK signaling is essential for osteoclast differentiation, activation and survival. In immunocytochemistry staining of osteoclasts for RANK, the groups subjected to a strain of 2,000 and 2,500 μɛ showed stronger positive staining than the control after 3 days of substrate stretching (Fig. 3B). These findings indicate that a mechanical strain of low magnitude within physiological load inhibits osteoclast differentiation, but promotes the fusion of mononuclear osteoclasts related to high magnitude strain. A strain of 5,000 μɛ regarded as high magnitude beyond physiological load had little effect (data not shown).

In RT-PCR analysis (Fig. 5), RANK mRNA expression decreased with the mechanical strain of 1,000, 1,500 and 5,000 μɛ, while both RANK and MMP-9 increased with the mechanical strain of 2,000 and 2,500 μɛ compared to the control. RANK mediated the ability of precursor cells to undergo differentiation. The selective inhibition of RANK with RANK:Fc or RANK receptor inhibitor has been shown to block osteoclast maturation and function in vivo or in vitro (25–27). MMP-9 has been proven to be indispensable for the migration of osteoclasts through collagen, both in the periosteum and developing marrow cavity of primitive long bones (28,29). MMP-9 antisense oligonucleotides exert an inhibitory effect on osteoclastic bone resorption by suppressing cell migration (30). Bone resorption is specifically reduced by the chemical inhibition of MMP-9 (31,32). The results of this study suggest the involvement of both RANK and MMP-9 expression depending on the mechanical strain magnitude, thus indicating that low-magnitude strain suppresses osteoclast differentiation, while high-magnitude strain within physiological load stimulates osteoclast fusion and activation.

We examined the apoptotic osteoclasts under mechanical strain. Compared to the control, apoptotic osteoclasts increased with the mechanical strain of 1,000 and 1,500 μɛ, whereas there was no significant stimulation was observed with a strain of 2,000, 2,500 and 5,000 μɛ (Fig. 4), suggesting that apoptosis occurs when a mechanical strain of low magnitude is applied. A heatmap produced by the heatmap function from R intuitively indicated the diverse trends of cell survival between the groups of different mechanical strain magnitudes as well.

Currently, mechanical exercise appears to be a concern for clinicians as a co-ordinated treatment. Little is known about how different magnitudes of mechanical strain exert an effect on the differentiation and fusion of osteoclasts. The data from our study provide a further understanding of the diverse regulation by different magnitudes of mechanical strain, leading to the development of therapeutics optimized for diseases related to bone loss. We found that mechanical strain turned out to be inhibitory towards RAW264.7 cell differentiation at a low magnitude, but stimulatory at a high magnitude within physiological load. The osteoclasts morphologically changed depending on the different magnitudes mechanical strain. The expression of RANK and related genes also changed depending on different magnitutes of strain. TRAP is often used as one of the macrophage/osteoclast lineage markers (33,34). However, the results of the present study on mRNA expression are in disagreement with those from the study of Fujisaki et al, who observed that the expression of CAII and cathepsin K induced by RANKL was increased according to the maturity and differentiation of the RAW264.7 cells (35). No significant differences were observed in the expression of TRAP, cathepsin K and CAII mRNA under mechanical strain compared to the control. Therefore, RANKL/osteoprotegerin-dependent signal transduction pathways are possibly more active during late differentiation than TRAP-dependent pathways. However, further study of other co-stimulators and/or mechanisms unknown during various stages of osteoclast development differentially regulated by mechanical strain is warranted.

Acknowledgements

The authors are grateful to their colleagues at the Institute of Medical Equipment, Academy of Military Medical Science, for their tremendous support. The study was supported by the National Natural Science Foundation Key Program of China (no. 10832012).

References

1 

Frost HM: Bone Remodeling Dynamics. Thomas CC: Springfield, IL: 1963

2 

Frost HM: Bone ‘mass’ and the ‘mechanostat’: a proposal. Anat Rec. 219:1–9. 1987.

3 

Teitelbaum SL: Osteoclasts: what do they do and how do they do it? Am J Pathol. 170:427–435. 2007.

4 

Kodama H, Nose M, Niida S and Yamasaki A: Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 173:1291–1294. 1991.

5 

Yasuda H, Shima N, Nakagawa N, et al: Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology. 139:1329–1337. 1998.

6 

Mochizuki A, Takami M, Kawawa T, et al: Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-kappa B ligand. J Immunol. 177:4360–4368. 2006.

7 

Kong YY, Yoshida H, Sarosi I, et al: OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 397:315–323. 1999.

8 

Kim N, Odgren PR, Kim DK, Marks SC Jr and Choi Y: Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene. Proc Nat Acad Sci USA. 97:10905–10910. 2000.

9 

Dougall WC, Glaccum M, Charrier K, et al: RANK is essential for osteoclast and lymph node development. Genes Dev. 13:2412–2424. 1999.

10 

Li J, Sarosi I, Yan XQ, et al: RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Nat Acad Sci USA. 97:1566–1571. 2000.

11 

Chen XY, Zhang XZ, Guo Y, Li RX, Lin JJ and Wei Y: The establishment of a mechanobiology model of bone and functional adaptation in response to mechanical loading. Clin Biomech (Bristol, Avon). 23(Suppl 1): 88–95. 2008.

12 

Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT and Martin TJ: Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endoc Rev. 20:345–357. 1999.

13 

Suzuki N, Yoshimura Y, Deyama Y, Suzuki K and Kitagawa Y: Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells. Int J Mol Med. 21:291–296. 2008.

14 

Takahashi N, Udagawa N, Tanaka S and Suda T: Generating murine osteoclasts from bone marrow. Methods Mol Med. 80:129–144. 2003.

15 

Tang LL, Wang YL, Pan J and Cai SX: The effect of step-wise increased stretching on rat calvarial osteoblast collagen production. J Biomech. 37:157–161. 2004.

16 

Shibata K, Yoshimura Y, Kikuiri T, et al: Effect of the release from mechanical stress on osteoclastogenesis in RAW264.7 cells. Int J Mol Med. 28:73–79. 2011.

17 

Kreja L, Liedert A, Hasni S, Claes L and Ignatius A: Mechanical regulation of osteoclastic genes in human osteoblasts. Biochem Biophys Res Commun. 368:582–587. 2008.

18 

Rubin J, Murphy T, Nanes MS and Fan X: Mechanical strain inhibits expression of osteoclast differentiation factor by murine stromal cells. Am J Physiol. 278:C1126–1132. 2000.

19 

Ichimiya H, Takahashi T, Ariyoshi W, Takano H, Matayoshi T and Nishihara T: Compressive mechanical stress promotes osteoclast formation through RANKL expression on synovial cells. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 103:334–341. 2007.

20 

Rubin J, Fan X, Biskobing DM, Taylor WR and Rubin CT: Osteoclastogenesis is repressed by mechanical strain in an in vitro model. J Orthop Res. 17:639–645. 1999.

21 

Burger EH, Klein-Nulend J and Smit TH: Strain-derived canalicular fluid flow regulates osteoclast activity in a remodelling osteon – a proposal. J Biomech. 36:1453–1459. 2003.

22 

McAllister TN, Du T and Frangos JA: Fluid shear stress stimulates prostaglandin and nitric oxide release in bone marrow-derived preosteoclast-like cells. Biochem Biophys Res Commun. 270:643–648. 2000.

23 

Kurata K, Uemura T, Nemoto A, et al: Mechanical strain effect on bone-resorbing activity and messenger RNA expressions of marker enzymes in isolated osteoclast culture. J Bone Miner Res. 16:722–730. 2001.

24 

Zhang Q, Liang X, Zhu B, et al: Effects of fluid shear stress on mRNA expression of carbonic anhydrase II in polarized rat osteoclasts. Cell Biol Int. 30:714–720. 2006.

25 

Childs LM, Paschalis EP, Xing L, et al: In vivo RANK signaling blockade using the receptor activator of NF-κB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. J Bone Miner Res. 17:192–199. 2002.

26 

Feeley BT, Liu NQ, Conduah AH, et al: Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration. J Bone Miner Res. 21:1571–1580. 2006.

27 

Kim H, Choi HK, Shin JH, et al: Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J Clin Invest. 119:813–825. 2009.

28 

Blavier L and Delaisse JM: Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci. 108:3649–3659. 1995.

29 

Sato T, Foged NT and Delaissé JM: The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors. J Bone Miner Res. 13:59–66. 1998.

30 

Ishibashi O, Niwa S, Kadoyama K and Inui T: MMP-9 antisense oligodeoxynucleotide exerts an inhibitory effect on osteoclastic bone resorption by suppressing cell migration. Life Sci. 79:1657–1660. 2006.

31 

Hill PA, Murphy G, Docherty AJ, et al: The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci. 107(Pt 11): 3055–3064. 1994.

32 

Spessotto P, Rossi FM, Degan M, et al: Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol. 158:1133–1144. 2002.

33 

Alatalo SL, Halleen JM, Hentunen TA, Monkkonen J and Vaananen HK: Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into the culture medium. Clin Chem. 46:1751–1754. 2000.

34 

Rissanen JP, Suominen MI, Peng Z and Halleen JM: Secreted tartrate-resistant acid phosphatase 5b is a Marker of osteoclast number in human osteoclast cultures and the rat ovariectomy model. Calcif Tissue Int. 82:108–115. 2008.

35 

Fujisaki K, Tanabe N, Suzuki N, et al: Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells. Life Sci. 80:1311–1318. 2007.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu X, Guo C, Yan Y, Guo Y, Li R, Song M and Zhang X: Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells. Mol Med Rep 6: 409-415, 2012.
APA
Xu, X., Guo, C., Yan, Y., Guo, Y., Li, R., Song, M., & Zhang, X. (2012). Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells. Molecular Medicine Reports, 6, 409-415. https://doi.org/10.3892/mmr.2012.908
MLA
Xu, X., Guo, C., Yan, Y., Guo, Y., Li, R., Song, M., Zhang, X."Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells". Molecular Medicine Reports 6.2 (2012): 409-415.
Chicago
Xu, X., Guo, C., Yan, Y., Guo, Y., Li, R., Song, M., Zhang, X."Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells". Molecular Medicine Reports 6, no. 2 (2012): 409-415. https://doi.org/10.3892/mmr.2012.908
Copy and paste a formatted citation
x
Spandidos Publications style
Xu X, Guo C, Yan Y, Guo Y, Li R, Song M and Zhang X: Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells. Mol Med Rep 6: 409-415, 2012.
APA
Xu, X., Guo, C., Yan, Y., Guo, Y., Li, R., Song, M., & Zhang, X. (2012). Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells. Molecular Medicine Reports, 6, 409-415. https://doi.org/10.3892/mmr.2012.908
MLA
Xu, X., Guo, C., Yan, Y., Guo, Y., Li, R., Song, M., Zhang, X."Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells". Molecular Medicine Reports 6.2 (2012): 409-415.
Chicago
Xu, X., Guo, C., Yan, Y., Guo, Y., Li, R., Song, M., Zhang, X."Differential effects of mechanical strain on osteoclastogenesis and osteoclast-related gene expression in RAW264.7 cells". Molecular Medicine Reports 6, no. 2 (2012): 409-415. https://doi.org/10.3892/mmr.2012.908
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team